Andes Virus DNA Vaccine for the Prevention of Hantavirus Pulmonary Syndrome Using the PharmaJet Stratis(R) Needle-Free Injection Delivery Device
Clinical trial NCT03682107 · COMPLETED
Trial details
- NCT number
- NCT03682107
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-19
- Primary completion
- 2020-09-23
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.